EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting
... in over 400 patients in multiple Phase 1 and 2 clinical trials. , MD, MBA, EntreMed Vice President and Chief Medical Officer commented on the results, "Although we did ...
More...
... in over 400 patients in multiple Phase 1 and 2 clinical trials. , MD, MBA, EntreMed Vice President and Chief Medical Officer commented on the results, "Although we did ...
More...